cholangiocarcinoma, intrahepatic, FGFR, FGFR2, FGFR inhibotor
Obesity, pancreatic cancer, NGF, NrCAM, iDISCO imaging, cytokines, neurons, catecholamines, chemokines, cytokines, MDSC, macrophages
gastric cancer, esophageal cancer, gastroesophageal junction cancer, immunotherapy
Gastric cancer, esophageal cancer, gastroesophageal junction cancer, Immunotherapy
pancreatic cancer, colorectal cancer, poly (ADP-ribose) polymerase, DNA damage, 5-fluorodeoxyuridine, PARP inhibitor, TAS102, trifluorothymidine, base excision repair